Ursolic acid–loaded chitosan nanoparticles suppress 7,12-dimethylbenz(a)anthracene-induced oral tumor formation through their antilipid peroxidative potential in golden Syrian hamsters

Oral cancer, a disfiguring and life threatening cancer, significantly affects the day-to-day life of not only the patients but also their family members in terms of life quality and financial burden. India records higher incidence of oral cancer every year and is mainly due to the habituation of tob...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Naunyn-Schmiedeberg's archives of pharmacology 2023-11, Vol.396 (11), p.3061-3074
Hauptverfasser: Karthik, Mohan, Manoharan, Shanmugam, Muralinaidu, Radhakrishnan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3074
container_issue 11
container_start_page 3061
container_title Naunyn-Schmiedeberg's archives of pharmacology
container_volume 396
creator Karthik, Mohan
Manoharan, Shanmugam
Muralinaidu, Radhakrishnan
description Oral cancer, a disfiguring and life threatening cancer, significantly affects the day-to-day life of not only the patients but also their family members in terms of life quality and financial burden. India records higher incidence of oral cancer every year and is mainly due to the habituation of tobacco products and alcohol abuse. Delay in diagnosis and treatment influences India’s higher incidence of oral cancer, where annually 50,000–60,000 oral carcinoma cases are reported. 7,12-dimethylbenz(a)anthracene (DMBA)-induced cancer in the oral cavity mimics human oral cancer in histopathological, molecular, and morphological aspects, and thus, by using this paradigm, the tumor inhibiting efficacy of medicinal plants or herbs and their components is scientifically validated. Ursolic acid, due to its multiple pharmacological effects, has been attracted, in recent years, for chemoprevention research program. Though, ursolic acid has been shown to have beneficial effects, its poor water solubility and bioavailability hinder to exert its 100% efficacy. Therefore, ursolic acid is encapsulated in either natural or synthetic polymers to enhance its therapeutic efficacy. Chitosan is one of the natural polymers that have been employed in the synthesis of nanoparticles to improve the drug efficacy. The present study has thus chosen ursolic acid–loaded chitosan nanoparticles (UACNP) to assess its anticancer efficacy in the DMBA-induced oral carcinoma. The anticancer efficacy of UACNP in experimental oral carcinogenesis was assessed by employing the status of oxidative markers and detoxification cascade as an end point. DMBA-induced abnormalities in the status of oxidative markers and detoxification cascade were reversed by ursolic acid–loaded chitosan nanoparticles. The tumor inhibiting or suppressing effect of UACNP is thus explored in experimental oral carcinogenesis.
doi_str_mv 10.1007/s00210-023-02509-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2811939938</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2811939938</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-c7c1764336dd77a952a6ef601e7787a4ae639a031d1d2fde5a33797ef27eb8ee3</originalsourceid><addsrcrecordid>eNp9kc2KFTEQhYMoznX0BVxIwM0ItubndqezlME_GHChs27qJtW3M6STNkkPXle-g2_j4_gkRu-o4MJFUYvznVMFh5CHnD3jjKnnmTHBWcOErNMy3YhbZMO3UjRcc3GbbKreN1zo_oTcy_mKMdbxtr1LTqTinWi3YkO-XaYcvTMUjLPfv3z1ESxaaiZXYoZAA4S4QCrOeMw0r8uSMGeqnnLRWDdjmQ5-h-HzGTyBUKYEBgM2LtjV1JiYwNOyzjHRMaYZiouBViqu-6ludIlWl_NucZYumOInZyt0jXSJBatS7S7QffQWA31_SK6-NMGcC6Z8n9wZwWd8cLNPyeWrlx_O3zQX716_PX9x0Rip2tIYZbjqtlJ21ioFuhXQ4dgxjkr1CraAndTAJLfcitFiC1IqrXAUCnc9ojwlZ8fcJcWPK-YyzC4b9B4CxjUPoudcS61lX9HH_6BXcU2hflcp1Xay0y2vlDhSJsWcE47DktwM6TBwNvxsdjg2O9Rmh1_NDqKaHt1Er7sZ7R_L7yorII9ArlLYY_p7-z-xPwAeV7Rf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2875636951</pqid></control><display><type>article</type><title>Ursolic acid–loaded chitosan nanoparticles suppress 7,12-dimethylbenz(a)anthracene-induced oral tumor formation through their antilipid peroxidative potential in golden Syrian hamsters</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Karthik, Mohan ; Manoharan, Shanmugam ; Muralinaidu, Radhakrishnan</creator><creatorcontrib>Karthik, Mohan ; Manoharan, Shanmugam ; Muralinaidu, Radhakrishnan</creatorcontrib><description>Oral cancer, a disfiguring and life threatening cancer, significantly affects the day-to-day life of not only the patients but also their family members in terms of life quality and financial burden. India records higher incidence of oral cancer every year and is mainly due to the habituation of tobacco products and alcohol abuse. Delay in diagnosis and treatment influences India’s higher incidence of oral cancer, where annually 50,000–60,000 oral carcinoma cases are reported. 7,12-dimethylbenz(a)anthracene (DMBA)-induced cancer in the oral cavity mimics human oral cancer in histopathological, molecular, and morphological aspects, and thus, by using this paradigm, the tumor inhibiting efficacy of medicinal plants or herbs and their components is scientifically validated. Ursolic acid, due to its multiple pharmacological effects, has been attracted, in recent years, for chemoprevention research program. Though, ursolic acid has been shown to have beneficial effects, its poor water solubility and bioavailability hinder to exert its 100% efficacy. Therefore, ursolic acid is encapsulated in either natural or synthetic polymers to enhance its therapeutic efficacy. Chitosan is one of the natural polymers that have been employed in the synthesis of nanoparticles to improve the drug efficacy. The present study has thus chosen ursolic acid–loaded chitosan nanoparticles (UACNP) to assess its anticancer efficacy in the DMBA-induced oral carcinoma. The anticancer efficacy of UACNP in experimental oral carcinogenesis was assessed by employing the status of oxidative markers and detoxification cascade as an end point. DMBA-induced abnormalities in the status of oxidative markers and detoxification cascade were reversed by ursolic acid–loaded chitosan nanoparticles. The tumor inhibiting or suppressing effect of UACNP is thus explored in experimental oral carcinogenesis.</description><identifier>ISSN: 0028-1298</identifier><identifier>EISSN: 1432-1912</identifier><identifier>DOI: 10.1007/s00210-023-02509-2</identifier><identifier>PMID: 37162542</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>9,10-Dimethyl-1,2-benzanthracene ; 9,10-Dimethyl-1,2-benzanthracene - toxicity ; Acids ; Alcohol abuse ; Animals ; Anthracene ; Bioavailability ; Biomedical and Life Sciences ; Biomedicine ; Carcinogenesis ; Carcinogenesis - pathology ; Carcinoma ; Chitosan ; Cricetinae ; Detoxification ; Drug abuse ; Habituation ; Head &amp; neck cancer ; Herbal medicine ; Humans ; Lipid Peroxidation ; Medicinal plants ; Mesocricetus ; Mouth Neoplasms - chemically induced ; Mouth Neoplasms - drug therapy ; Mouth Neoplasms - prevention &amp; control ; Nanoparticles ; Neurosciences ; Oral cancer ; Oral carcinoma ; Oral cavity ; Pharmacology/Toxicology ; Quality of life ; Tumors ; Ursolic Acid</subject><ispartof>Naunyn-Schmiedeberg's archives of pharmacology, 2023-11, Vol.396 (11), p.3061-3074</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-c7c1764336dd77a952a6ef601e7787a4ae639a031d1d2fde5a33797ef27eb8ee3</citedby><cites>FETCH-LOGICAL-c375t-c7c1764336dd77a952a6ef601e7787a4ae639a031d1d2fde5a33797ef27eb8ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00210-023-02509-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00210-023-02509-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37162542$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Karthik, Mohan</creatorcontrib><creatorcontrib>Manoharan, Shanmugam</creatorcontrib><creatorcontrib>Muralinaidu, Radhakrishnan</creatorcontrib><title>Ursolic acid–loaded chitosan nanoparticles suppress 7,12-dimethylbenz(a)anthracene-induced oral tumor formation through their antilipid peroxidative potential in golden Syrian hamsters</title><title>Naunyn-Schmiedeberg's archives of pharmacology</title><addtitle>Naunyn-Schmiedeberg's Arch Pharmacol</addtitle><addtitle>Naunyn Schmiedebergs Arch Pharmacol</addtitle><description>Oral cancer, a disfiguring and life threatening cancer, significantly affects the day-to-day life of not only the patients but also their family members in terms of life quality and financial burden. India records higher incidence of oral cancer every year and is mainly due to the habituation of tobacco products and alcohol abuse. Delay in diagnosis and treatment influences India’s higher incidence of oral cancer, where annually 50,000–60,000 oral carcinoma cases are reported. 7,12-dimethylbenz(a)anthracene (DMBA)-induced cancer in the oral cavity mimics human oral cancer in histopathological, molecular, and morphological aspects, and thus, by using this paradigm, the tumor inhibiting efficacy of medicinal plants or herbs and their components is scientifically validated. Ursolic acid, due to its multiple pharmacological effects, has been attracted, in recent years, for chemoprevention research program. Though, ursolic acid has been shown to have beneficial effects, its poor water solubility and bioavailability hinder to exert its 100% efficacy. Therefore, ursolic acid is encapsulated in either natural or synthetic polymers to enhance its therapeutic efficacy. Chitosan is one of the natural polymers that have been employed in the synthesis of nanoparticles to improve the drug efficacy. The present study has thus chosen ursolic acid–loaded chitosan nanoparticles (UACNP) to assess its anticancer efficacy in the DMBA-induced oral carcinoma. The anticancer efficacy of UACNP in experimental oral carcinogenesis was assessed by employing the status of oxidative markers and detoxification cascade as an end point. DMBA-induced abnormalities in the status of oxidative markers and detoxification cascade were reversed by ursolic acid–loaded chitosan nanoparticles. The tumor inhibiting or suppressing effect of UACNP is thus explored in experimental oral carcinogenesis.</description><subject>9,10-Dimethyl-1,2-benzanthracene</subject><subject>9,10-Dimethyl-1,2-benzanthracene - toxicity</subject><subject>Acids</subject><subject>Alcohol abuse</subject><subject>Animals</subject><subject>Anthracene</subject><subject>Bioavailability</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Carcinogenesis</subject><subject>Carcinogenesis - pathology</subject><subject>Carcinoma</subject><subject>Chitosan</subject><subject>Cricetinae</subject><subject>Detoxification</subject><subject>Drug abuse</subject><subject>Habituation</subject><subject>Head &amp; neck cancer</subject><subject>Herbal medicine</subject><subject>Humans</subject><subject>Lipid Peroxidation</subject><subject>Medicinal plants</subject><subject>Mesocricetus</subject><subject>Mouth Neoplasms - chemically induced</subject><subject>Mouth Neoplasms - drug therapy</subject><subject>Mouth Neoplasms - prevention &amp; control</subject><subject>Nanoparticles</subject><subject>Neurosciences</subject><subject>Oral cancer</subject><subject>Oral carcinoma</subject><subject>Oral cavity</subject><subject>Pharmacology/Toxicology</subject><subject>Quality of life</subject><subject>Tumors</subject><subject>Ursolic Acid</subject><issn>0028-1298</issn><issn>1432-1912</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kc2KFTEQhYMoznX0BVxIwM0ItubndqezlME_GHChs27qJtW3M6STNkkPXle-g2_j4_gkRu-o4MJFUYvznVMFh5CHnD3jjKnnmTHBWcOErNMy3YhbZMO3UjRcc3GbbKreN1zo_oTcy_mKMdbxtr1LTqTinWi3YkO-XaYcvTMUjLPfv3z1ESxaaiZXYoZAA4S4QCrOeMw0r8uSMGeqnnLRWDdjmQ5-h-HzGTyBUKYEBgM2LtjV1JiYwNOyzjHRMaYZiouBViqu-6ludIlWl_NucZYumOInZyt0jXSJBatS7S7QffQWA31_SK6-NMGcC6Z8n9wZwWd8cLNPyeWrlx_O3zQX716_PX9x0Rip2tIYZbjqtlJ21ioFuhXQ4dgxjkr1CraAndTAJLfcitFiC1IqrXAUCnc9ojwlZ8fcJcWPK-YyzC4b9B4CxjUPoudcS61lX9HH_6BXcU2hflcp1Xay0y2vlDhSJsWcE47DktwM6TBwNvxsdjg2O9Rmh1_NDqKaHt1Er7sZ7R_L7yorII9ArlLYY_p7-z-xPwAeV7Rf</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Karthik, Mohan</creator><creator>Manoharan, Shanmugam</creator><creator>Muralinaidu, Radhakrishnan</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20231101</creationdate><title>Ursolic acid–loaded chitosan nanoparticles suppress 7,12-dimethylbenz(a)anthracene-induced oral tumor formation through their antilipid peroxidative potential in golden Syrian hamsters</title><author>Karthik, Mohan ; Manoharan, Shanmugam ; Muralinaidu, Radhakrishnan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-c7c1764336dd77a952a6ef601e7787a4ae639a031d1d2fde5a33797ef27eb8ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>9,10-Dimethyl-1,2-benzanthracene</topic><topic>9,10-Dimethyl-1,2-benzanthracene - toxicity</topic><topic>Acids</topic><topic>Alcohol abuse</topic><topic>Animals</topic><topic>Anthracene</topic><topic>Bioavailability</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Carcinogenesis</topic><topic>Carcinogenesis - pathology</topic><topic>Carcinoma</topic><topic>Chitosan</topic><topic>Cricetinae</topic><topic>Detoxification</topic><topic>Drug abuse</topic><topic>Habituation</topic><topic>Head &amp; neck cancer</topic><topic>Herbal medicine</topic><topic>Humans</topic><topic>Lipid Peroxidation</topic><topic>Medicinal plants</topic><topic>Mesocricetus</topic><topic>Mouth Neoplasms - chemically induced</topic><topic>Mouth Neoplasms - drug therapy</topic><topic>Mouth Neoplasms - prevention &amp; control</topic><topic>Nanoparticles</topic><topic>Neurosciences</topic><topic>Oral cancer</topic><topic>Oral carcinoma</topic><topic>Oral cavity</topic><topic>Pharmacology/Toxicology</topic><topic>Quality of life</topic><topic>Tumors</topic><topic>Ursolic Acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karthik, Mohan</creatorcontrib><creatorcontrib>Manoharan, Shanmugam</creatorcontrib><creatorcontrib>Muralinaidu, Radhakrishnan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Naunyn-Schmiedeberg's archives of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karthik, Mohan</au><au>Manoharan, Shanmugam</au><au>Muralinaidu, Radhakrishnan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ursolic acid–loaded chitosan nanoparticles suppress 7,12-dimethylbenz(a)anthracene-induced oral tumor formation through their antilipid peroxidative potential in golden Syrian hamsters</atitle><jtitle>Naunyn-Schmiedeberg's archives of pharmacology</jtitle><stitle>Naunyn-Schmiedeberg's Arch Pharmacol</stitle><addtitle>Naunyn Schmiedebergs Arch Pharmacol</addtitle><date>2023-11-01</date><risdate>2023</risdate><volume>396</volume><issue>11</issue><spage>3061</spage><epage>3074</epage><pages>3061-3074</pages><issn>0028-1298</issn><eissn>1432-1912</eissn><abstract>Oral cancer, a disfiguring and life threatening cancer, significantly affects the day-to-day life of not only the patients but also their family members in terms of life quality and financial burden. India records higher incidence of oral cancer every year and is mainly due to the habituation of tobacco products and alcohol abuse. Delay in diagnosis and treatment influences India’s higher incidence of oral cancer, where annually 50,000–60,000 oral carcinoma cases are reported. 7,12-dimethylbenz(a)anthracene (DMBA)-induced cancer in the oral cavity mimics human oral cancer in histopathological, molecular, and morphological aspects, and thus, by using this paradigm, the tumor inhibiting efficacy of medicinal plants or herbs and their components is scientifically validated. Ursolic acid, due to its multiple pharmacological effects, has been attracted, in recent years, for chemoprevention research program. Though, ursolic acid has been shown to have beneficial effects, its poor water solubility and bioavailability hinder to exert its 100% efficacy. Therefore, ursolic acid is encapsulated in either natural or synthetic polymers to enhance its therapeutic efficacy. Chitosan is one of the natural polymers that have been employed in the synthesis of nanoparticles to improve the drug efficacy. The present study has thus chosen ursolic acid–loaded chitosan nanoparticles (UACNP) to assess its anticancer efficacy in the DMBA-induced oral carcinoma. The anticancer efficacy of UACNP in experimental oral carcinogenesis was assessed by employing the status of oxidative markers and detoxification cascade as an end point. DMBA-induced abnormalities in the status of oxidative markers and detoxification cascade were reversed by ursolic acid–loaded chitosan nanoparticles. The tumor inhibiting or suppressing effect of UACNP is thus explored in experimental oral carcinogenesis.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>37162542</pmid><doi>10.1007/s00210-023-02509-2</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-1298
ispartof Naunyn-Schmiedeberg's archives of pharmacology, 2023-11, Vol.396 (11), p.3061-3074
issn 0028-1298
1432-1912
language eng
recordid cdi_proquest_miscellaneous_2811939938
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene - toxicity
Acids
Alcohol abuse
Animals
Anthracene
Bioavailability
Biomedical and Life Sciences
Biomedicine
Carcinogenesis
Carcinogenesis - pathology
Carcinoma
Chitosan
Cricetinae
Detoxification
Drug abuse
Habituation
Head & neck cancer
Herbal medicine
Humans
Lipid Peroxidation
Medicinal plants
Mesocricetus
Mouth Neoplasms - chemically induced
Mouth Neoplasms - drug therapy
Mouth Neoplasms - prevention & control
Nanoparticles
Neurosciences
Oral cancer
Oral carcinoma
Oral cavity
Pharmacology/Toxicology
Quality of life
Tumors
Ursolic Acid
title Ursolic acid–loaded chitosan nanoparticles suppress 7,12-dimethylbenz(a)anthracene-induced oral tumor formation through their antilipid peroxidative potential in golden Syrian hamsters
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T00%3A45%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ursolic%20acid%E2%80%93loaded%20chitosan%20nanoparticles%20suppress%207,12-dimethylbenz(a)anthracene-induced%20oral%20tumor%20formation%20through%20their%20antilipid%20peroxidative%20potential%20in%20golden%20Syrian%20hamsters&rft.jtitle=Naunyn-Schmiedeberg's%20archives%20of%20pharmacology&rft.au=Karthik,%20Mohan&rft.date=2023-11-01&rft.volume=396&rft.issue=11&rft.spage=3061&rft.epage=3074&rft.pages=3061-3074&rft.issn=0028-1298&rft.eissn=1432-1912&rft_id=info:doi/10.1007/s00210-023-02509-2&rft_dat=%3Cproquest_cross%3E2811939938%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2875636951&rft_id=info:pmid/37162542&rfr_iscdi=true